$OMER Income Statement | Understand Stock

$OMER

$17.49 +$1.20 (7.37%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Costs and expenses:
Research and development
Selling, general and administrative
Total costs and expenses
Loss from operations
Other income
Gain on sale of zaltenibart
Gain on early extinguishment of debt
Initial Term Loan
Convertible Senior Notes 2026
Total gain on early extinguishment of debt
Interest and other income
Interest expense, net of remeasurement adjustments and other
Gain (loss) on change in fair value of financial instruments, net
Loss from continuing operations before income tax expense
Income tax expense
Net loss from continuing operations, net of tax
Net income from discontinued operations, net of tax
Net loss

Basic and diluted net income (loss) per share:
Net loss from continuing operations (in dollars per share)
Net income from discontinued operations (in dollars per share)
Net loss (in dollars per share)
Weighted-average shares used to compute basic and diluted net income (loss) per share (in shares)

Comments